AusBiotech links with Japanese industry body on regenerative meds

AusBiotech signed a memorandum of understanding (MoU) with Japan’s peak regenerative medicine body, Forum for Innovative Regenerative Medicine (FIRM) last week) under the MoU between Australian Trade Commission (Austrade) and FIRM, in relation to the collaboration in advancing regenerative medicine and cell and gene therapies within Australia, Japan and worldwide.

FIRM is a Japanese general incorporated association with a mission to accelerate research and commercialization of regenerative medicine in Japan. FIRM was formed in 2011 and has more than 220 members of Japanese companies from various fields with diverse expertise in such as pharmaceutical, biotechnology, manufacturing, transportation, insurance and related supporting areas for regenerative medicine.

AusBiotech and FIRM will collaborate in advancing their individual and common missions by sharing information, encompassing technology, policy, laws, etc, and assist each other in co-sponsoring meetings or through other cooperation based on common concerns.